Precise binding free energy calculations unlock new frontiers in drug design
Drug discovery is a costly and time-intensive process, with binding free energy calculations between the potential drug ...
pharmaphorum7d
GSK collaborates on AI-driven drug design with Cloud Pharmaceuticals
Its deal with the US-based AI-driven drug design and development company will see Cloud design novel small-molecule agents to GSK-specified targets. Ed Addison, CEO of Cloud Pharmaceuticals ...
PharmiWeb24d
Oxford Drug Design achieves further in vivo validation of novel approach against multiple tumours
The innovative approach is based on the novel target leucyl-tRNA synthetase, belonging to the tRNA synthetase enzyme family on which Oxford Drug Design has developed a deep understanding. The new data ...
Novel quantum-classical computing scheme for designing light-sensitive compounds could accelerate material discovery
Recently, a joint research team developed a novel quantum-classical computing scheme for designing photochromic ...
PharmaTimes24d
Oxford Drug Design achieves in vivo validation for novel cancer treatment
Oxford Drug Design, the Oxford-based AI drug discovery company, has announced further in vivo validation for its first-in-class cancer treatment approach. The company is developing novel treatments ...
Scientists design peptides to enhance drug efficacy
Scientists have developed a groundbreaking approach using specially designed peptides to improve drug formulations. This innovative method significantly enhances anti-tumor efficacy.
pharmaphorum5d
Diving deeper into AI discovery, Sanofi signs 5-drug deal with Atomwise
"We are excited to partner with Atomwise, given their leadership in the field of virtual screening and AI-based molecular design ... with Exscientia for 15 novel drug candidates in January ...
EurekAlert!24d
A new geometric machine learning method promises to accelerate precision drug development
Some approaches have focused on screening for such small molecules, but we wanted to design a novel protein that would bind to a defined protein-drug complex.” He believes that “such designed ...